Patent · US Active

Process methods for phosphatidylinositol 3-kinase inhibitors

US10047060B2 · kind B2 · utility

7Cited by
67References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2017
Grant dateAug 14, 2018
Priority date
Expiry dateNov 17, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A process for the synthesis of quinazolinone containing compounds which may be useful for the treatment of cancer, is hereby disclosed. In addition, compound intermediates relating to these processes are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.